LEVATION PHARMA
LEVATION PHARMA
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Status:
Active
Total Funding:
1.1 M USD
Current Employees Featured
Founder
Investors List
Peregrine Ventures
Peregrine Ventures investment in Venture Round - Levation Pharma
Peregrine Ventures
Peregrine Ventures investment in Seed Round - Levation Pharma
More informations about "Levation Pharma"
Levation Pharma, Ltd
Levation Pharma, Ltd. is an Israeli-American company that was founded on the basis of intellectual property licensed from its Founders and relating to the treatment of Acquired Blepharoptosis. The company is funded by leading …See details»
Levation Pharma - Crunchbase Company Profile & Funding
Levation Pharma is located in Tel Aviv, Tel Aviv, Israel. Who invested in Levation Pharma? Levation Pharma is funded by Peregrine Ventures. How much funding has Levation Pharma …See details»
Levation Pharma - PitchBook
Developer of a topical oxymetazoline product designed to be used for cosmetic eye lifts.See details»
Lexitas | Ophthalmology CRO
Partner with a product development organization that’s 100% focused on delivering life-changing ophthalmic treatments to patients. Our team of skilled specialists, relationship builders and ophthalmic experts have a wealth of …See details»
Levation Pharma, Ltd. | LinkedIn
Levation Pharma, Ltd. Pharmaceutical Manufacturing A clinical stage pharmaceutical company developing new treatments for aesthetic and functional eyelid conditions.See details»
Levation Pharma Ltd. - Drug pipelines, Patents, Clinical trials
Levation Pharma, a pharmaceutical company focused on the development of new therapeutics for the ophthalmology and aesthetic space, received FDA clearance to initiate Phase I and II of …See details»
LEVATION PHARMA LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for LEVATION PHARMA LTD of TEL AVIV-JAFFA, Central District. Get the latest business insights from Dun …See details»
Levation pharma LTD - Company Profile and News - Bloomberg …
Company profile page for Levation pharma LTD including stock price, company news, executives, board members, and contact informationSee details»
Levation Pharma - Funding, Financials, Valuation & Investors
Levation Pharma is funded by Peregrine Ventures. Which investors participated in the most funding rounds?See details»
Levation Pharma - Products, Competitors, Financials, Employees ...
Levation Pharma focuses on the development of treatments for aesthetic and functional eyelid and facial conditions, operating in the pharmaceutical industry. Use the CB Insights Platform to …See details»
Press Release Distribution and Management - GlobeNewswire
LOS ANGELES, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Levation Pharma Ltd., a pharmaceutical company focused on the development of new therapeutics for the ophthalmology and …See details»
Levation Pharma Initiates Phase I/II Clinical Trial of - GlobeNewswire
LOS ANGELES, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Levation Pharma Ltd., a pharmaceutical company focused on the development of new therapeutics for the ophthalmology and …See details»
Oxymetazoline by Levation Pharma for Ptosis: Likelihood of Approval
Aug 28, 2024 · Levation Pharma (Levation) is developing of a topical oxymetazoline product or gel with acquired blepharoptosis designed to be used for cosmetic eye lifts. Levation is …See details»
Levation Pharma - Contacts, Employees, Board Members
Levation Pharma has 1 current employee profile, Co-Founder, Chief Scientific Officer Houman Hemmati.See details»
Levation Pharma Stock Price, Funding, Valuation, Revenue
See Levation Pharma funding rounds, investors, investments, exits and more. Evaluate their financials based on Levation Pharma's post-money valuation and revenue.See details»
Levation Pharma Initiates Phase I/II Clinical Trial of LEV102 for ...
LOS ANGELES, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Levation Pharma Ltd., a pharmaceutical company focused on the development of new therapeutics for the ophthalmology and …See details»
Acquired Blepharoptosis: Levation Pharma Launches Clinical Trial
Mar 6, 2023 · Levation Pharma is conducting a Phase I/IIa, multicenter, randomized, vehicle-controlled, double-masked, multiple-dose, parallel-group trial to evaluate the effects of LEV102 …See details»
Levation Pharma, Ltd. received an FDA clearance to initiate
Levation Pharma, Ltd. received an FDA clearance to initiate Phase I/II of LEV102 The clinical trial is designed to determine preliminary safety and efficacy signals for LEV102 as a potential …See details»
LEV102 2.0% and LEV102 1.0% and Vehicle in Acquired ... - ICH GCP
Jan 27, 2023 · March 12, 2024 updated by: Levation Pharma, Ltd. A Phase 1/2a Study of LEV102 Topical Gel in Subjects With Acquired Blepharoptosis Phase 1/2a, multicenter, randomized, …See details»
Home - Elevation Oncology
We are focused on discovering and developing selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs.See details»